Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 33 Colorectal Neoplasms 13 Neoplasms 11 Pain, Postoperative 10 Lung Neoplasms 9 Brain Neoplasms 8 Stomach Neoplasms 7 Prostatic Neoplasms 7 Pancreatic Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Melanoma 6 Leukemia, Myeloid, Acute 5 Ovarian Neoplasms 4 Myoma 4 Lymphoma, Non-Hodgkin 4 Leiomyoma 4 Hemorrhage 4 Head and Neck Neoplasms 4 Glioblastoma 4 Colonic Neoplasms 4 Agnosia 4 Skin Neoplasms 3 Recurrence 3 Rectal Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neurotoxicity Syndromes 3 Neoplasm Metastasis 3 Nasopharyngeal Carcinoma 3 Myelodysplastic Syndromes 3 Multiple Endocrine Neoplasia Type 1 3

Interventions

Bupivacaine 3 Lidocaine 2 Botulinum Toxins, Type A 2 Therapeutics 1 Sodium Chloride 1 Ralfinamide 1 Radiofrequency Ablation 1 Musculoskeletal Manipulations 1 Methylprednisolone 1 Lidoderm 1 Injections 1 Indocyanine Green 1 Dry Needling 1 Decompression 1 Cryosurgery 1 Cholecalciferol 1 Bevacizumab 1 Anesthetics, Local 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neuroma × Sodium Chloride × Clear all

NCT02930551 2019-02-08

Neuromas as the Cause of Pain

Danish Pain Research Center

Phase NA Completed

Neuralgia, Neuroma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡